If you would like to know more about the Type 1 Diabetes Prevention Trial, please phone 1300 138 712 or contact your closest trial site located in Australia (ADELAIDE, BRISBANE, MELBOURNE, PERTH, SYDNEY) or New Zealand (AUCKLAND).



Women’s and Children’s Hospital

Principal Investigator: Professor Jenny Couper
Site Coordinator: Sarah Beresford
Phone: 08-8161-7887
Fax: 08-8161-7759
Site Address: Department of Endocrinology and Diabetes
King William Street
North Adelaide SA 5006



Mater Children’s Hospital

Principal Investigator: Dr Andrew Cotterill
Site Coordinator: Julie Kirby
Phone: 07-3163-3722
Site Address: Endocrinology Department
Raymond Terrace
Brisbane QLD 4101



Royal Melbourne Hospital

Chief Investigators: Professor Peter Colman, Professor Len Harrison
Trial Coordinator: Candice Hall
Phone: 03-9342-7672
Fax: 03-9342-8634
Site Address: Burnet Clinical Research Unit
Royal Melbourne Hospital
Grattan Street
Parkville VIC 3050



Princess Margaret Hospital & Clinical Children’s Research Facility

Principal Investigator: Associate Professor Liz Davis, Professor Tim Jones
Site Coordinator: Alison Roberts
Phone: 08-9340-8486
Fax: 08-9340-8605
Site Address: Department of Endocrinology & Diabetes
Roberts Road
Subiaco WA 6008



The Children’s Hospital at Westmead

Principal Investigator: Associate Professor Kim Donoghue
Site Coordinator: Tracey Jopling
Phone: 02-9845-3158
Fax: 02-9845-3170
Site Address: Institute of Endocrinology
Hawkesbury Road
Westmead NSW 2145


New Zealand


Liggins Institute

Principal Investigator: Dr Craig Jefferies
Site Coordinator: Suzanne Mannering
Phone: 64-9-923-7897
Site Address: Liggins Institute
University of Auckland
85 Park Rd
Grafton Auckland, New Zealand


The Principal Investigators (specialist doctors) conducting this study are Professor Leonard C. Harrison and Associate Professor Peter Colman, Royal Melbourne Hospital, Melbourne.

This trial has received Ethics Committee approval and will be conducted in conjunction with your usual doctor and should not interfere with any other treatment. All study-specific questions can be addressed at the site or on the telephone.

Study participants travelling to the site will be reimbursed for travel expenses they may incur. Frequent travel to the study site is not required.

Comments are closed.